Sgs Pharmaceutical Pvt Ltd - Company Profile

Q: Who are the current directors of Sgs Pharmaceutical Pvt Ltd?

The current directors of Sgs Pharmaceutical Pvt Ltd are Nimish Gupta, Manvendra Singh.

It is a pharma private limited company based in New Elhi, Delhi, India, established in 2001.

2001 New Elhi, Delhi, India Active

Last Updated: December 18, 2025

About Sgs Pharmaceutical Pvt Ltd

Sgs Pharmaceutical Pvt Ltd, a active private limited company, was established on 08 May 2001 in New Elhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239DL2001PTC110738. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.75 Cr and a paid-up capital of ₹1.30 Cr.

It upholds a compliant status. Employing 62 professional, Its leadership includes Nimish Gupta (Director), Manvendra Singh (Director). Past directors included Anita Gupta, Vipin Gupta, Pramod Kumar. It holds ₹15.22 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1608 Dewan Hall Building6/2 Ist Floor Bhagirathi Place, New Elhi, Delhi, 110006.

Company Details

CIN/LLPIN
U24239DL2001PTC110738
Registration Number
110738
Incorporation Date
08 May 2001
Authorized Capital
₹1.75 Cr
Paid-Up Capital
₹1.30 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.75 Cr as on 18-12-2025
Paid Up Capital ₹ 1.30 Cr as on 18-12-2025
Company Age 24 Year, 9 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 15.22 Cr as on 18-12-2025
Revenue Growth **** -26.66% (FY 2023)
Profit Growth **** 14.48% (FY 2023)
Ebitda **** -13.01% (FY 2023)
Net Worth 14.04% (FY 2023)
Total Assets **** 1.54% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Sgs Pharmaceutical Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sgs Pharmaceutical Pvt Ltd?

Current Directors

Name	Designation	Appointment Date	Status
Nimish Gupta	Director	20 Feb 2007	Current
Manvendra Singh	Director	30 Jan 2019	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	01 Jan 2014	Past
Pramod Abcsdd	Director	21 Feb 2019	Past
Pramod Abcsdd	Additional Director	30 Sep 2019	Past
Pramod Abcsdd	Additional Director	30 Sep 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sgs Pharmaceutical.

Sgs Pharmaceutical Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.66% decrease. The company also saw a substantial improvement in profitability, with a 14.48% increase in profit. The company's net worth Soared by an impressive increase of 14.04%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-26.66%

*******

Revenue from Operations

*******

-26.73%

*******

Total Assets

*******

1.54%

*******

Profit or Loss

*******

14.48%

*******

Net Worth

*******

14.04%

*******

EBITDA

*******

-13.01%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sgs Pharmaceutical?

In 2024, Sgs Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹152,157,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

State Bank Of India : 14.87 Cr
Hdfc Bank Limited : 0.35 Cr

Latest Charge Details

Date	Lender	Amount	Status
29 Oct 2020	Hdfc Bank Limited	₹3.50 M	Open
04 Jan 2006	State Bank Of India	₹10.51 Cr	Open
04 Jan 2006	State Bank Of India	₹3.36 Cr	Open
04 Jan 2006	State Bank Of India	₹1.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Sgs Pharmaceutical?

Sgs Pharmaceutical has a workforce of 62 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sgs Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sgs Pharmaceutical's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sgs Pharmaceutical

Recent Activity within the Organization

Annual General Meeting

Sgs Pharmaceutical Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
30 Sep 2024
Balance Sheet

Sgs Pharmaceutical Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
31 Mar 2024
Charges

A charge with State Bank Of India of Rs. 10.51 Cr registered on 04 Jan 2006 with Charge ID 80061610 was modified on 10 Jul 2023. was recorded as a recent event.
10 Jul 2023
Charges

Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.35 Cr with Charge ID 100418251 was registered on 29 Oct 2020. was documented.
29 Oct 2020
Director Appointment

Progress on Manvendra Singh was appointed as a Director was appointed as a Director on 30 Jan 2019 & has been associated with this company since 7 years 11 days . was documented.
30 Jan 2019
Charges

Progress on A charge with State Bank Of India of Rs. 3.36 Cr registered on 04 Jan 2006 with Charge ID 90331256 was modified on 29 Nov 2010. was documented.
29 Nov 2010

Explore recent activity and updates - View Recent Activity